A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
Article Abstract:
Placing a filter in the vena cava to prevent blood clots from spreading from the legs to the lungs may have serious complications. The vena cava is the large vein that returns blood to the heart. In 400 patients who had blood clots in the large veins of the leg, 200 were given a filter in the vena cava and 200 were not. Initially, those with a filter had fewer blood clots in the lungs, but within two years, they were more likely to have recurring blood clots in the legs. This may occur because blood clots form around the filter. Low-molecular-weight heparin was as effective as unfractionated heparin in preventing blood clots in these patients.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Article Abstract:
Long-term use of diet pills containing fenfluramine or its derivatives may increase the risk of pulmonary hypertension. This lung disease is characterized by high blood pressure in the blood vessels of the lungs. Researchers compared the use of fenfluramine and its derivatives by 95 people with pulmonary hypertension and 355 healthy volunteers. Use of fenfluramine and its derivatives led to a six-fold increased risk of pulmonary hypertension. Those who took the drugs for more than three months had 23 times the risk.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: a systematic review of the evidence
Article Abstract:
Animal studies show that fenfluramine and its derivative dexfenfluramine both cause damage to nerve cells in the brain that produce serotonin. It is not known whether this occurs in humans. These appetite suppressants go by the trade names Pondimin and Redux, respectively. A review of the animal studies found that the doses that cause damage in animals are the same doses used in humans to treat obesity. These drugs also increase the risk of pulmonary hypertension, especially when used for more than 3 months.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome
- Abstracts: Multicenter clinical trial of ibuprofen and acetaminophen in the treatment of postoperative dental pain. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures
- Abstracts: Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: a novel potential intravaginal virucide
- Abstracts: Deficiencies in calculation and applied mathematics skills in pediatrics among primary care interns. A drop in pediatric subject examination scores after curriculum changes that emphasize general pediatric topics
- Abstracts: Body protein in prepubertal children with phenylketonuria. Variations in the measurement of resting energy expenditure in children with cystic fibrosis